Identification of an ataxia telangiectasia-mutated protein mediated surveillance system to regulate Bcl-2 overexpression

Oncogene
J ZhangDamu Tang

Abstract

Bcl-2 can both promote and attenuate tumorigenesis. Although the former function is relatively well characterized, the mechanism of the latter remains elusive. We report here that enforced Bcl-2 expression in MCF7 cells stabilizes p53, induces phosphorylation of p53 serine 15 (p53pSer15) and inhibits MCF7 cell growth. Consistent with p53 Ser15 being a target of ataxia telangiectasia mutated protein(ATM)/ATR (ATM- and rad3-related) in the DNA damage response, Bcl-2 activates ATM by inducing ATM Ser1981 phosphorylation, which is accompanied with the phosphorylaton of two additional ATM substrates, Chk2 Thr68 and H2AX Ser139. Downregulation of ATM using a specific small interference RNA fragment (ATMRNAi) abolished Bcl-2-induced p53pSer15 and Bcl-2-mediated growth inhibition of MCF7 cells. Ectopic expression of a dominant-negative p53 mutant, p53175H, partially rescued this growth inhibition. Taken together, these observations demonstrate the contribution of ATM-p53 function to Bcl-2-mediated inhibition of MCF7 cell growth, indicating an ATM-mediated surveillance system for regulating Bcl-2 overexpression. Consistent with this concept, we found that MCF7 cells express Bcl-2 heterogeneously with 34.5% of cells being Bcl-2 negative....Continue Reading

References

Feb 1, 1977·British Journal of Urology·P H O'ReillyH J Testa
Aug 1, 1995·British Journal of Cancer·P HellemansE Van Marck
May 1, 1996·Genes & Development·L J Ko, C Prives
Jun 1, 1996·Social Science & Medicine·S FordS Lewis
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·G P LinetteS J Korsmeyer
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·S KharbandaD Kufe
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C CharpinC Allasia
Aug 8, 1998·Genes & Development·E de StanchinaS W Lowe
Sep 23, 1998·Nature·I PalmeroM Serrano
Jan 5, 2000·Oncogene·F CongS P Goff
Mar 25, 2000·Endocrine-related Cancer·M G DaidoneR Silvestrini
Apr 25, 2000·Cell Death and Differentiation·D D NewmeyerD R Green
Feb 1, 2002·The Journal of Biological Chemistry·Damu TangAlistair J Ingram
Jul 9, 2002·Apoptosis : an International Journal on Programmed Cell Death·J J JagerJ W Arends
Oct 22, 2002·Nature Cell Biology·Zaher NahleScott W Lowe
Nov 26, 2002·Nature Cell Biology·Richard A DiTullioThanos D Halazonetis
Jan 31, 2003·Nature·Christopher J Bakkenist, Michael B Kastan
Mar 4, 2003·Nature Reviews. Cancer·Yosef Shiloh
Oct 14, 2003·Biochemical Pharmacology·Scott A OakesLuca Scorrano
Mar 5, 2004·Biochimica Et Biophysica Acta·Vladimir KirkinMartin Zörnig
Jul 10, 2004·Cell·Christopher J Bakkenist, Michael B Kastan

❮ Previous
Next ❯

Citations

Mar 30, 2011·Cancer Research·Corentin LaulierBernard S Lopez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.